Welcome to the Highlights from International Kidney Cancer Symposium resource center. This is your central portal for research presented at the meeting. The resource center — which includes traditional articles and video commentaries — provides a comprehensive overview of advances related to all aspects of cancer. Many articles will be accompanied by perspectives in which experts put study results in context and offer insights into how findings will affect patient care.
Meeting NewsVideo
November 17, 2017
MIAMI — Saby George, MD, FACS, offered background in special considerations that should be taken when treating patients with metastatic renal…
Meeting NewsVideo
November 15, 2017
MIAMI Combination use of ipilimumab plus nivolumab can be considered the standard of care for the frontline treatment of patients with metastatic…
Meeting News
November 6, 2017
MIAMI — The combination of atezolizumab and bevacizumab demonstrated encouraging activity as first-line treatment for PD-L1-positive metastatic…
Meeting NewsVideo
November 5, 2017
MIAMI Patients with brain metastases from renal cell carcinoma should undergo local treatment when possible, according to a presenter at…
Meeting News
November 4, 2017
MIAMI Despite varying guidelines, surveillance and ablation may have an increasing role in the management of small renal masses, according to a…
Meeting News
November 4, 2017
MIAMI — Patients with metastatic renal cell carcinoma who had vertebral metastasis achieved significantly shorter survival than patients who…
Meeting News
November 4, 2017
MIAMI Elderly patients are underrepresented in clinical trials of treatments for metastatic renal cell carcinoma, according to a presenter at…
Meeting News
November 4, 2017
MIAMI — Nivolumab induced more durable responses than everolimus among patients with advanced renal cell carcinoma, according to 3-year…
Meeting News
November 4, 2017
MIAMI — Brain metastases from renal cell carcinoma have negative prognostic implications, and the number and size of those metastases greatly…
Meeting News
November 4, 2017
MIAMI — Vascular endothelial growth factor inhibitors may augment the efficacy observed with immuno-oncology agents for first-line treatment of…